Cellectar BiosciencesCLRB
13F holders, Q1 2025 (March 31)32holders +2
7new positions
6sold out
1famous investor
$0.31avg. 13F price*
At the end of Q1 2025, 32 institutions reported holding Cellectar Biosciences Inc. (CLRB) in their 13F filings, up 2 from Q4 2024. 7 opened new positions and 6 sold out. The largest holders were Vanguard Group Inc. ($542K), UBS Group AG ($290K) and Geode Capital Management, LLC ($140K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Cellectar Biosciences Inc.
- CUSIP
- 15117F807
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $181K |
| Exits | 6 | $85K |
All 13F filers, Q4 2024 → Q1 2025: 1,638,942 shares bought and 1,572,712 shares sold, net +66,230 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 32 holders
| Vanguard Group Inc. | 0.00% | Reduce -0.3% | 1,721,838 | $542K |
| UBS Group AG | 0.00% | Add +144.6% | 920,352 | $290K |
| Geode Capital Management, LLC | 0.00% | Add +26.4% | 443,424 | $140K |
| Squarepoint Ops LLC | 0.00% | Reduce -28.7% | 370,865 | $117K |
| Citadel Advisors | 0.00% | New | 343,258 | $108K |
| BlackRock, Inc. | 0.00% | Reduce -0.7% | 230,814 | $73K |
| Sequoia Financial Advisors, LLC | 0.00% | Add +1301.8% | 203,260 | $64K |
| Simplex Trading, LLC | 0.00% | Add +324.9% | 173,129 | $54K |
| Baader Bank Aktiengesellschaft | 0.00% | New | 172,940 | $43K |
| State Street Corp. | 0.00% | No change | 128,114 | $40K |
| XTX Topco Ltd | 0.00% | Add +122.5% | 104,323 | $33K |
| Two Sigma Investments, LP | 0.00% | Add +16.9% | 83,099 | $26K |
| Northern Trust Corp. | 0.00% | No change | 77,988 | $25K |
| HRT Financial LP | 0.00% | New | 46,236 | $14K |
| Rochester Wealth Strategies, LLC | 0.01% | — | 43,000 | $14K |
| ADAR1 Capital Management, LLC | 0.00% | Reduce -93.1% | 40,228 | $13K |
| Nordwand Advisors, LLC | 0.00% | New | 20,000 | $6K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | New | 17,587 | $6K |
| Morgan Stanley | 0.00% | Reduce -91.4% | 15,305 | $5K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 12,051 | $4K |
| Oppenheimer & Co. Inc. | 0.00% | No change | 12,500 | $4K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -74.5% | 10,807 | $3K |
| Commerce Bank | 0.00% | New | 10,000 | $3K |
| EverSource Wealth Advisors, LLC | 0.00% | New | 1,646 | $519 |
| Group One Trading LLC | 0.00% | No change | 1,398 | $441 |
| Osaic Holdings, Inc. | 0.00% | Reduce -66.2% | 921 | $293 |
| SBI Securities Co., Ltd. | 0.00% | No change | 400 | $126 |
| Bank of America Corp. | 0.00% | Reduce -99.8% | 347 | $109 |
| US Bancorp \de | 0.00% | Reduce -74.0% | 100 | $32 |
| JPMorgan Chase & Co. | 0.00% | Reduce -100.0% | 76 | $24 |
| Harbour Investments, Inc. | 0.00% | Add +25.0% | 50 | $16 |
| AllSquare Wealth Management LLC | 0.00% | No change | 18 | $6 |
"% of holder's portfolio" is CLRB's weight in each manager's 13F, not the share of Cellectar Biosciences Inc. the manager owns.